↓ Skip to main content

Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1+ Myeloma Cells and Release Type-1 Cytokines

Overview of attention for article published in Frontiers in oncology, May 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1+ Myeloma Cells and Release Type-1 Cytokines
Published in
Frontiers in oncology, May 2020
DOI 10.3389/fonc.2020.00544
Pubmed ID
Authors

Lawrence G. Lum, Archana Thakur, Abdalla Elhakiem, Lena Alameer, Emily Dinning, Manley Huang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 18%
Other 2 12%
Researcher 2 12%
Student > Ph. D. Student 1 6%
Lecturer 1 6%
Other 0 0%
Unknown 8 47%
Readers by discipline Count As %
Medicine and Dentistry 4 24%
Immunology and Microbiology 2 12%
Nursing and Health Professions 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Engineering 1 6%
Other 0 0%
Unknown 8 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2022.
All research outputs
#7,210,695
of 25,387,668 outputs
Outputs from Frontiers in oncology
#2,462
of 22,433 outputs
Outputs of similar age
#149,492
of 413,273 outputs
Outputs of similar age from Frontiers in oncology
#69
of 461 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,273 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 461 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.